drugset / Trial / NCT06435221
Safety Study of Cytisinicline in Adult Combustible and/or E-cigarette Smokers
NaSingle-groupOpen-labelTreatment
Summary
Safety assessment of long-term 3 mg cytisinicline three times daily (TID) exposure for 52 weeks is the main purpose of this study, conducted in the United States.
Timeline
- Start
- 2024-05-28
- Primary completion
- 2025-09-29
- Completion
- 2025-10-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cytisinicline | Small molecule | 3 mg | Oral |
Indications
No indication recorded.